Comparative Analysis of Two Animal-derived ADMs in Irradiated Implant-based Reconstruction

NCT ID: NCT06139588

Last Updated: 2023-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

146 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-01

Study Completion Date

2023-10-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this retrospective observational trial is to compare two different devices, used in implant-based breast reconstruction, called acellular dermal matrices, which are a sort of collagen patch that integrates with the tissues of the patient and helps in contrasting the collateral effects of radiotherapy (capsular contracture, implant loss)

The main questions the study aims to answer are:

* is one of the two matrices better than the other? (better results with fewer complications)
* is there a group of patients who benefit more than another from the use of this type of devices?
* is there an adm which works better in one specific subgroup of patients? Participants have undergone mastectomy, radiotherapy and implant reconstruction with the aid of two different kinds of acellular dermal matrices.

Researchers will compare patients who receive the porcine-derived adm and the patients who receive bovine-derived adm to see if there is a difference in terms of capsular contracture reduction, aestethic result and complications.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Radiotherapy is highly effective in breast cancer treatment, yet it impairs satisfactory implant-based reconstruction, due to high rates of capsular contracture and implant loss. This said, a fervent investigtion exists upon solutions that can make implant-based reconstruction safer and aesthetically satisfying, including the use of acellular dermal matrices. We retrospectively want to analyze our ADM-assisted post-RT implant-based breast reconstructions comparing two different matrices (porcine and bovine), when autologous reconstruction was contraindicated, to assess eventual differences in efficacy and risk profile of the devices. We want to further stratify the population in 4 groups based on clinical presentation to assess if there was a group where ADMs proves to perform better (Group A - previous quadrantectomy, Group B - previous mastectomy and expander reconstruction, Group C - previous mastectomy and implant reconstruction, Group D - prior quadrantectomy followed by mastectomy and implant reconstruction).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Implant; Complications Breast Implant Infection Implant Capsular Contracture Breast Seroma Breast Implant Protrusion Breast Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

implant-based breast reconstruction adm radiation therapy irradiated breast

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

POST QUART NATIVE

Native adm used in the setting of mastectomy and implant reconstruction after QUART

acellular dermal matrix implant for breast reconstruction

Intervention Type DEVICE

acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy

POST QUART VERITAS

Veritas adm used in the setting of mastectomy and implant reconstruction after QUART

acellular dermal matrix implant for breast reconstruction

Intervention Type DEVICE

acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy

POST EXPANDER NATIVE

Native adm used in the setting of expander removal and implant positioning after mastectomy + RT

acellular dermal matrix implant for breast reconstruction

Intervention Type DEVICE

acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy

POST EXPANDER VERITAS

Veritas adm used in the setting of expander removal and implant positioning after mastectomy + RT

acellular dermal matrix implant for breast reconstruction

Intervention Type DEVICE

acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy

IMPLANT EXCHANGE NATIVE

Native adm used in the setting of implant exchange after mastectomy + RT

acellular dermal matrix implant for breast reconstruction

Intervention Type DEVICE

acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy

IMPLANT EXCHANGE VERITAS

Veritas adm used in the setting of implant exchange after mastectomy + RT

acellular dermal matrix implant for breast reconstruction

Intervention Type DEVICE

acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy

IMPANT EXCHANGE AFTER QUART NATIVE

Native adm used in the setting of implant exchange after QUART+ Mastectomy and implant reconstruction

acellular dermal matrix implant for breast reconstruction

Intervention Type DEVICE

acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy

IMPLANT EXCHANGE AFTER QUART VERITAS

Veritas adm used in the setting of implant exchange after QUART+ Mastectomy and implant reconstruction

acellular dermal matrix implant for breast reconstruction

Intervention Type DEVICE

acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

acellular dermal matrix implant for breast reconstruction

acellular dermal matrix implant in implant-based breast reconstruction in patients receiving radiotherapy

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* at least 6 months follow up
* breast reconstruction with implant + acellular dermal matrix after mastectomy and radiotherapy

Exclusion Criteria

* mastectomy flap \<1 cm
* autoimmune disease
* prolonged use of corticosteroids
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

European Institute of Oncology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andrea Vittorio Emanuele Lisa, MD

Role: PRINCIPAL_INVESTIGATOR

Istituto Europeo di Oncologia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

European Institute of Oncology

Milan, Lombardy, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UID4321

Identifier Type: -

Identifier Source: org_study_id